CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,383,812
- in 18 filings, $13.4M under 10b5-1 plans
Net −$32,383,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-06 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −499 | $30.53 | $15K | 377,802 |
| 2026-10-06 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 332,253 | ||
| 2026-10-05 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-10-05 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −6,699 | $28.82 | $193K | 382,984 |
| 2026-10-05 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −5,182 | $29.67 | $154K | 377,802 |
| 2026-10-05 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 344,134 | ||
| 2026-10-02 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-10-02 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −11,881 | $28.13 | $334K | 377,802 |
| 2026-10-02 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 356,015 | ||
| 2026-10-01 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-10-01 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −6,081 | $27.57 | $168K | 383,602 |
| 2026-10-01 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −5,800 | $28.56 | $166K | 377,802 |
| 2026-10-01 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 367,896 | ||
| 2026-10-01 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +8,038 | $8.46 | $68K | 228,905 |
| 2026-10-01 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +9,377 | $3.99 | $37K | 238,282 |
| 2026-10-01 | LO FRANCIS Chief People Officer | Option exercise 10b5-1 | +9,377 | $8.12 | $76K | 247,659 |
| 2026-10-01 | LO FRANCIS Chief People Officer | Sale 10b5-1 | −8,094 | $27.52 | $223K | 239,565 |
| 2026-10-01 | LO FRANCIS Chief People Officer | Sale 10b5-1 | −18,698 | $28.61 | $535K | 220,867 |
| 2026-10-01 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −8,038 | 16,075 | ||
| 2026-10-01 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −9,377 | 56,259 |
Page 6 of 119 · 2,375 trades